AAF
Andra AP-fonden Portfolio holdings
AUM
$7.19B
1-Year Return
17.43%
This Quarter Return
+4.91%
1 Year Return
+17.43%
3 Year Return
+74.99%
5 Year Return
–
10 Year Return
–
AUM
$3.95B
AUM Growth
+$109M
(+2.8%)
Cap. Flow
-$17.3M
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
4.59%
Holding
606
New
48
Increased
270
Reduced
258
Closed
25
Top Buys
| 1 |
Reliance Steel & Aluminium
RS
|
$13.3M |
| 2 |
Albertsons Companies
ACI
|
$12.3M |
| 3 |
Builders FirstSource
BLDR
|
$11.5M |
| 4 |
Dick's Sporting Goods
DKS
|
$10.6M |
| 5 |
Deckers Outdoor
DECK
|
$9.55M |
Top Sells
| 1 |
Thomson Reuters
TRI
|
$15.8M |
| 2 |
Trip.com Group
TCOM
|
$13.9M |
| 3 |
Teva Pharmaceuticals
TEVA
|
$11.3M |
| 4 |
McKesson
MCK
|
$10.8M |
| 5 |
Check Point Software Technologies
CHKP
|
$9.03M |
Sector Composition
| 1 | Technology | 21.04% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 13.63% |
| 4 | Financials | 12.54% |
| 5 | Industrials | 12.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
IBM
IBM
$232B
| $7.83M | 0.2% |
58,500
-800
| -1% | -$107K |
|
202
Thermo Fisher Scientific
TMO
$186B
| $7.83M | 0.2% |
14,998
-700
| -4% | -$365K |
|
203
Akamai
AKAM
$11.3B
| $7.8M | 0.2% |
86,800
-16,600
| -16% | -$1.49M |
|
204
United Therapeutics
UTHR
$18.1B
| $7.79M | 0.2% |
+35,300
| New | +$7.79M |
|
205
Jazz Pharmaceuticals
JAZZ
$7.86B
| $7.79M | 0.2% |
62,800
+27,300
| +77% | +$3.38M |
|
206
Apollo Global Management
APO
$75.3B
| $7.78M | 0.2% |
101,317
-17,900
| -15% | -$1.37M |
|
207
MSCI
MSCI
$42.9B
| $7.74M | 0.2% |
16,500
+1,200
| +8% | +$563K |
|
208
Garmin
GRMN
$45.7B
| $7.74M | 0.2% |
74,200
+20,400
| +38% | +$2.13M |
|
209
Bank of New York Mellon
BK
$73.1B
| $7.72M | 0.2% |
173,400
+24,800
| +17% | +$1.1M |
|
210
Marriott International Class A Common Stock
MAR
$71.9B
| $7.72M | 0.2% |
42,007
+17,500
| +71% | +$3.21M |
|
211
Kellanova
K
$27.8B
| $7.71M | 0.2% |
121,836
-5,325
| -4% | -$337K |
|
212
Corpay
CPAY
$22.4B
| $7.71M | 0.2% |
30,700
-18,600
| -38% | -$4.67M |
|
213
Archer Daniels Midland
ADM
$30.2B
| $7.7M | 0.19% |
101,900
+33,200
| +48% | +$2.51M |
|
214
Alnylam Pharmaceuticals
ALNY
$59.2B
| $7.69M | 0.19% |
40,500
-4,700
| -10% | -$893K |
|
215
ON Semiconductor
ON
$20.1B
| $7.69M | 0.19% |
81,300
-47,800
| -37% | -$4.52M |
|
216
Expedia Group
EXPE
$26.6B
| $7.68M | 0.19% |
70,200
+16,400
| +30% | +$1.79M |
|
217
T-Mobile US
TMUS
$284B
| $7.64M | 0.19% |
55,000
+13,500
| +33% | +$1.88M |
|
218
C.H. Robinson
CHRW
$14.9B
| $7.61M | 0.19% |
80,700
-48,900
| -38% | -$4.61M |
|
219
State Street
STT
$32B
| $7.61M | 0.19% |
104,000
+32,500
| +45% | +$2.38M |
|
220
Visa
V
$666B
| $7.61M | 0.19% |
32,041
-18,400
| -36% | -$4.37M |
|
221
CarMax
KMX
$9.11B
| $7.59M | 0.19% |
90,700
+5,800
| +7% | +$485K |
|
222
Fidelity National Financial
FNF
$16.5B
| $7.57M | 0.19% |
210,200
+25,900
| +14% | +$932K |
|
223
Moderna
MRNA
$9.78B
| $7.56M | 0.19% |
62,200
+13,400
| +27% | +$1.63M |
|
224
Labcorp
LH
$23.2B
| $7.55M | 0.19% |
36,433
-6,868
| -16% | -$1.42M |
|
225
Weyerhaeuser
WY
$18.9B
| $7.53M | 0.19% |
224,800
+33,800
| +18% | +$1.13M |
|